Data / Form D filings / HOPE-Neuron Therapeutx, Inc.
HOPE-Neuron Therapeutx, Inc.: Form D filing
HOPE-Neuron Therapeutx, Inc., a biotechnology company in Phoenix, AZ, filed a Form D with the SEC in 2026. The latest, on July 2, 2026, reports $150,000 sold of a $150,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4308 N 16TH AVE, Phoenix, AZ, 85015
- Phone
- (305) 239-7657
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2143357
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | New notice | $150,000 | $150,000 | 1 | Jun 12, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronald Howard Lane | Executive Officer | Founder and Executive Chairman |
| Mark Forney | Executive Officer | VP of Business Development |
| John Louf | Executive Officer | Chief Technology Officer |
| Karina Fedasz | Executive Officer | Interim Chief Financial Officer |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Jun 29, 2026 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what HOPE-Neuron Therapeutx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.